全文获取类型
收费全文 | 2994篇 |
免费 | 266篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 79篇 |
妇产科学 | 160篇 |
基础医学 | 383篇 |
口腔科学 | 52篇 |
临床医学 | 502篇 |
内科学 | 457篇 |
皮肤病学 | 38篇 |
神经病学 | 211篇 |
特种医学 | 73篇 |
外科学 | 332篇 |
综合类 | 45篇 |
一般理论 | 2篇 |
预防医学 | 446篇 |
眼科学 | 24篇 |
药学 | 203篇 |
中国医学 | 2篇 |
肿瘤学 | 230篇 |
出版年
2023年 | 22篇 |
2022年 | 27篇 |
2021年 | 67篇 |
2020年 | 42篇 |
2019年 | 83篇 |
2018年 | 80篇 |
2017年 | 64篇 |
2016年 | 56篇 |
2015年 | 61篇 |
2014年 | 86篇 |
2013年 | 175篇 |
2012年 | 195篇 |
2011年 | 175篇 |
2010年 | 97篇 |
2009年 | 86篇 |
2008年 | 152篇 |
2007年 | 176篇 |
2006年 | 155篇 |
2005年 | 131篇 |
2004年 | 118篇 |
2003年 | 122篇 |
2002年 | 138篇 |
2001年 | 78篇 |
2000年 | 57篇 |
1999年 | 64篇 |
1998年 | 34篇 |
1997年 | 21篇 |
1996年 | 20篇 |
1995年 | 14篇 |
1994年 | 21篇 |
1993年 | 22篇 |
1992年 | 54篇 |
1991年 | 42篇 |
1990年 | 45篇 |
1989年 | 38篇 |
1988年 | 42篇 |
1987年 | 35篇 |
1986年 | 30篇 |
1985年 | 34篇 |
1984年 | 22篇 |
1983年 | 19篇 |
1979年 | 20篇 |
1978年 | 19篇 |
1977年 | 13篇 |
1975年 | 15篇 |
1974年 | 20篇 |
1972年 | 17篇 |
1970年 | 24篇 |
1969年 | 16篇 |
1968年 | 16篇 |
排序方式: 共有3261条查询结果,搜索用时 0 毫秒
1.
2.
3.
Digital mammography using storage phosphor CR is still in the investigational stage. It is the only digital mammography system that has been tested in preliminary clinical trials with promising early results. Further clinical studies are needed to assess the impact of the limited spatial resolution of storage phosphor technology on its application as a digital screening mammography system. Further studies also are needed to determine the optimum image processing parameters needed in digital mammography. 相似文献
4.
B A Quinn T L Crane T E Kocal S J Best R G Cameron T H Rushmore E Farber M A Hayes 《Toxicology and applied pharmacology》1990,105(3):351-363
To evaluate the role of glutathione S-transferase (GST) isoenzymes in induced resistance of hepatocytes to aflatoxin B1 (AFB1), we compared DNA protective activities of different hepatic cytosol preparations and purified GSTs from normal rats, rats exposed to different polychlorinated biphenyls (PCBs), and rats with carcinogen-induced hepatocellular neoplasms, with cytosols or purified GSTs from mouse, rainbow trout, and human livers. These comparisons were performed in an in vitro assay for [3H]AFB1-DNA binding after activation by rat liver microsomes. Cytosol and S-hexylglutathione-affinity-purified GST preparations from livers of mice consistently had strong protective activity against AFB1-DNA binding. The majority of this activity was dependent on the presence of reduced glutathione (GSH) but some GSH-independent protection was observed in mouse hepatic cytosol, but not in purified GST preparations. We found that all of the GSH-dependent DNA-protective activity in mouse liver eluted as a single GST isoenzyme by hydroxyapatite chromatography. Preparations of cytosol and purified GSTs from normal rat liver, rainbow trout liver, and human liver had much less AFB1-specific DNA protective activity than GSTs found in mouse liver preparations. Cytosol from rats with carcinogen-generated liver neoplasms and livers induced with 3,3',4,4'-tetrachlorobiphenyl and 2,2',4,4',5,5'-hexachlorobiphenyl had more GST activity toward CDNB than cytosol from normal rat liver. When equivalent units of GST activity (CDNB) were compared, there was little difference observed between the DNA-protective activities of PCB-induced and normal rat liver cytosols, yet cytosol from rat liver neoplasms was more protective. Purified GST-P (7-7), the GST isoenzyme most induced in carcinogen-generated rat liver neoplasms, was not protective when added at protein concentrations found to be protective for total GSTs isolated from these neoplasms. These studies demonstrate that the resistance of mouse liver to AFB1 can be explained primarily by a single constitutive GST isoenzyme (YaYa or 4-4) with a relatively high activity toward DNA-binding metabolites of AFB1. GST isoenzymes with such high specific DNA protective activity against AFB1 metabolites were not evident in human, rat, or rainbow trout liver or in PCB-induced or neoplastic rat liver preparations. 相似文献
5.
6.
7.
Evaluating food fortification options: general principles revisited with folic acid. 总被引:6,自引:3,他引:3
下载免费PDF全文
![点击此处可从《American journal of public health》网站下载免费的PDF全文](/ch/ext_images/free.gif)
N T Crane D B Wilson D A Cook C J Lewis E A Yetley J I Rader 《American journal of public health》1995,85(5):660-666
OBJECTIVES. This article uses folic acid as an example to illustrate some of the complex issues and general principles that emerge when evaluating fortification of the food supply as one possible means to address a public health recommendation. METHODS. Distributions of current daily folate intakes from conventional foods and dietary supplements were estimated. Intakes that might result from fortification of cereal-grain products and ready-to-eat cereals at various levels for eight age-gender groups were also estimated by using the US Department of Agriculture's 1987-1988 Nationwide Food Consumption Survey. RESULTS. The results illustrate that fortification of the US food supply tends to increase folate intakes of consumers at the high end of the intake distribution curves in the general population to a greater extent than it affects consumers at the low end of the intake distribution curves in the target population. CONCLUSIONS. The effectiveness of food fortification options for a target population and the safety for the general population impose conflicting challenges that must be considered concurrently when making decisions about fortifying the US food supply. 相似文献
8.
M A Crane 《The New England journal of medicine》1992,326(21):1429-30; author reply 1430-1
9.
Dr. Douglas N. Fish Pharm. D. Ms. Jacquelyn L. Bainbridge B.S. Pharm. Dr. Charles A. Peloquin Pharm. D. 《Pharmacotherapy》1995,15(2):236-245
Continuous arteriovenous hemodiafiltration (CAVHD) is being used increasingly in critically ill patients with acute renal failure (ARF). We prospectively evaluated extracorporeal and total systemic clearances (ClCAVHD and Cls) of ciprofloxacin during CAVHD in four patients with severe ARF to assess the adequacy of drug dosing. Ciprofloxacin serum and ultrafiltrate concentrations were measured by high-performance liquid chromatography. The ClCAVHD accounted for approximately 5.9% (range 2.8–11.6%) of Cls of ciprofloxacin. However, large variability in serum concentrations was observed with the normally recommended dose of 400 mg/day, and doses of up to 800 mg/day were required to maintain concentrations suitable for treatment of serious infections. High daily doses of ciprofloxacin required in these patients are likely related to altered pharmacokinetics in serious illness as well as to the increased extracorporeal clearance during CAVHD. Clinical studies to define appropriate dosing recommendations for ciprofloxacin during CAVHD are necessary to guide clinicians in optimum drug use. 相似文献
10.
Kazumasa Fujitani Jaffer A. Ajani Christopher H. Crane Barry W. Feig Peter W. Pisters Nora Janjan Garrett L. Walsh Stephen G. Swisher Ara A. Vaporciyan David Rice Angela Welch Jackie Baker Josephine Faust Paul F. Mansfield MD 《Annals of surgical oncology》2007,14(4):1305-1311
Background Significant tumor downstaging has been achieved in patients with localized gastric or gastroesophageal adenocarcinoma by induction
chemotherapy and preoperative chemoradiotherapy (CTX–CTXRT). However, the influence of CTX–CTXRT on operative morbidity and
mortality has not yet been clarified. The aim of the present study was to document the frequency and nature of morbidity and
mortality after surgery combined with CTX–CTXRT, and identify factors predictive of postoperative complications in patients
with localized gastric or gastroesophageal adenocarcinoma.
Methods A prospectively collected database on 71 consecutive patients who underwent CTX–CTXRT at M.D. Anderson Cancer Center between
January 1997 and August 2004 was reviewed. Postoperative morbidity and mortality were investigated, and risk factors for overall
complications were identified by multivariate logistic regression analysis.
Results Overall morbidity and mortality rates were 38.0% (27 patients) and 2.8% (2 patients), respectively. Age greater than 60 years
[relative risk 11.3 (95% confidence interval 2.50–50.6)] and body mass index (BMI) of 26 kg/m2 or above [relative risk 4.08 (95% confidence interval 1.08–15.4)] were significant risk factors for overall complications.
Conclusions CTX–CTXRT can be performed safely with an acceptable operative morbidity and a low operative mortality rate in patients with
gastric or gastroesophageal cancer, with careful consideration of added risk associated with age and obesity. 相似文献